Investeringsoversigt

4538 investments
Titel Sort descending Periode Program
WidePathCamper 2018 - 2019 Innobooster View project, WidePathCamper
Wind turbine aerodynamic enhancement for increasing energy capture 2019 - 2020 Innobooster View project, Wind turbine aerodynamic enhancement for increasing energy capture
Wireless Acoustic Myography for animals, sports and hospitals 2020 - 2021 Innobooster View project, Wireless Acoustic Myography for animals, sports and hospitals
Wireless Bar Management System 2017 - 2017 Innobooster View project, Wireless Bar Management System
Wisdome WFA 3.0 2020 - 2020 Innobooster View project, Wisdome WFA 3.0
Wise Home - Platformen for intelligente bygninger 2019 - 2022 Innobooster View project, Wise Home - Platformen for intelligente bygninger
Women Power Factory - Made to order Diabetes sko 2020 - 2021 Innobooster View project, Women Power Factory - Made to order Diabetes sko
Wood decor akustik produkt 2020 - 2021 Innobooster View project, Wood decor akustik produkt
WOOF - databaseret trivselsarbejde i grundskolen 2024 - 2025 Innobooster View project, WOOF - databaseret trivselsarbejde i grundskolen
WordPay.io: ansøgning om bevilling til udvikling af teknologisk forbrugersegmentering 2022 - 2022 Innobooster View project, WordPay.io: ansøgning om bevilling til udvikling af teknologisk forbrugersegmentering
WordPay.io: Ansøgning om støtte til udvikling af analytics-modul 2021 - 2021 Innobooster View project, WordPay.io: Ansøgning om støtte til udvikling af analytics-modul
Workee - job portal for large recruiters 2021 - 2021 Innobooster View project, Workee - job portal for large recruiters
Workee ApS 2020 - 2020 Innobooster View project, Workee ApS
Workflow for MR-scanning af aktive implantater 2024 - 2025 Innobooster View project, Workflow for MR-scanning af aktive implantater
Worlds first effective treatment of Atopic Dermatitis (eczema) based on a unique LBP drug candidate 2022 - 2023 Innobooster View project, Worlds first effective treatment of Atopic Dermatitis (eczema) based on a unique LBP drug candidate